Sana Biotechnology Inc (NAS:SANA)
$ 7.5 -0.11 (-1.45%) Market Cap: 1.66 Bil Enterprise Value: 1.46 Bil PE Ratio: 0 PB Ratio: 4.42 GF Score: 39/100

Sana Biotechnology Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 06:55PM GMT
Release Date Price: $6.71 (-4.55%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. Good afternoon, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Really pleased to have Steve Harr, the CEO of Sana with me.

Just quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosure.

So with that, Steve and I are going to switch places. He's going to ask questions, I'm going to answer now.

Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director

Great. That'll be fun. I think people might enjoy that more.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

And -- but Steve, thanks for being here. I thought maybe a good place to start. It's just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot